New HPV vaccine aims to protect against more Cancer-Causing virus types

NCT ID NCT06688058

Ongoing ⭐️ VACCINE ⭐️ Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 07, 2026 · Updated 24 times

Summary

This early-stage study tests a new vaccine called V540D that may protect against more types of HPV than current vaccines. HPV can cause certain cancers, and this vaccine is designed to cover additional virus types. The study involves 72 healthy adults and focuses on safety and how well the body responds to the vaccine.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Alliance for Multispecialty Research, LLC ( Site 0003)

Kansas City, Missouri, 64114, United States
Alliance for Multispecialty Research, LLC ( Site 0004)

Knoxville, Tennessee, 37920, United States
Research Centers of America ( Hollywood ) ( Site 0001)

Hollywood, Florida, 33024, United States
Velocity Clinical Research, Savannah ( Site 0005)

Savannah, Georgia, 31406, United States

Conditions

Explore the condition pages connected to this study.

HEALTHY